急性肾损伤相关的医疗保健费用
该研究纳入加拿大阿尔伯塔省239,906例住院成人,依据肌酐定义AKI分期并随访90天肾脏恢复情况,从住院、门诊及医生账单估算费用。结果显示AKI严重程度、透析需求及未恢复均与显著增量费用相关,且持续至入院后12个月。
要点
- AKI严重程度越高,住院时间与费用增量越大,3期透析者费用增量最高。
- AKI后90天未恢复肾脏功能者,3-12个月费用增量高于已恢复者。
- 加拿大AKI年增量费用估计超过2亿加元。
核心结论
- AKI严重程度、透析需求及肾脏未恢复与显著医疗费用相关,且持续至入院后一年。
主要发现
- AKI 1、2、3期未透析及3期透析分别占25,495例(10.6%)、4,598例(1.9%)、2,493例(1.0%)和670例(0.3%)。
- AKI严重程度增加与住院时间延长(+2.8天至+7.4天)及费用增加(+$3,779至+$18,291加元)相关,从入院至恢复评估(3个月)。
- 入院后3-12个月,与无AKI者相比,AKI伴肾脏恢复者增量费用为+$2,912至+$3,231加元,未恢复者为+$6,035至+$8,563加元。
- 加拿大AKI年增量费用估计超过2亿加元。
关键数值与推荐
- AKI定义依据住院前6个月门诊血肌酐确定基线肾功能,住院前14天血肌酐定义AKIN分期。
- 肾脏恢复定义为AKI后90天血肌酐在基线25%以内且脱离透析。
- 费用以2015年加元计,来源于住院、门诊及医生索赔数据集。
临床怎么用
- 临床应重视AKI严重程度、透析需求及肾脏恢复情况对长期医疗资源的影響。
- 促进肾脏恢复的策略可能有助于降低AKI相关医疗费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: An understanding of the health care resource use associated with AKI is needed to frame the investment and cost-effectiveness of strategies to prevent AKI and promote kidney recovery. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We assembled population-based cohort of adults hospitalized in Alberta between November of 2002 and March of 2009 without ESRD or an eGFR<15 ml/min per 1.73 m2. Outpatient serum creatinine measurements 6 months preceding admission defined baseline kidney function, and serum creatinine during the first 14 days of hospitalization defined Acute Kidney Injury Network stage; kidney recovery defined as serum creatinine within 25% of baseline and independence from dialysis was assessed at 90 days after AKI. Health care utilization and costs (in 2015 Canadian dollars) were determined from inpatient, outpatient, and physician claims datasets during the index hospitalization, recovery period (90 days post-AKI assessment), and 3-12 months post-AKI. A fully adjusted generalized linear model regression analysis was used to estimate costs associated with AKI. RESULTS: Of 239,906 hospitalized subjects, 25,495 (10.6%), 4598 (1.9%), 2493 (1.0%), and 670 (0.3%) had Acute Kidney Injury Network stages 1, 2, 3 without dialysis, and 3 with dialysis, respectively. Greater severity of AKI was associated with incremental increases in length of stay (+2.8; 95% confidence interval, 1.4 to 4.3 to +7.4; 95% confidence interval, 7.2 to 7.5 days) and costs (+$3779; 95% confidence interval, $3555 to $4004 to +$18,291; 95% confidence interval, $15,573 to $21,009 Canadian dollars) from admission to recovery assessment (3 months). At months 3-12 postadmission, compared with subjects without AKI, AKI with kidney recovery and AKI without kidney recovery were associated with incremental costs of +$2912-$3231 and +$6035-$8563 Canadian dollars, respectively. The estimated incremental cost of AKI in Canada is estimated to be over $200 million Canadian dollars per year. CONCLUSIONS: Severity of AKI, need for dialysis, and lack of kidney recovery are associated with significant health care costs in hospitalized patients and persist a year after admission. Strategies to identify, prevent, and facilitate kidney recovery are needed.
引用
- Collister D, Pannu N, Ye F, et al. Health Care Costs Associated with AKI. Clin J Am Soc Nephrol. 2017. PMID: 29051143. doi:10.2215/CJN.00950117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。